We are live on
!
Find out more
DMK
David M. Knott Portfolio holdings
AUM
$275M
1-Year Est. Return
59.23%
This Fund
S&P 500
This Quarter
Est. Return
+23.53%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
–
AUM
$221M
AUM Growth
+$50.5M
(+30%)
Cap. Flow
+$20.5M
Cap. Flow
% of AUM
9.26%
Top 10 Holdings %
Top 10 Hldgs %
55.64%
Holding
119
New
19
Increased
16
Reduced
14
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDWT
Midwest Holding Inc. Common Stock
MDWT
|
+$8.29M |
| 2 |
DNMR
Danimer Scientific, Inc.
DNMR
|
+$6.71M |
| 3 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$4.06M |
| 4 |
Gilead Sciences
GILD
|
+$3.25M |
| 5 |
Eastern Bankshares
EBC
|
+$2.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRCL
Stericycle Inc
SRCL
|
+$10.1M |
| 2 |
LKQ Corp
LKQ
|
+$1.03M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
+$917K |
| 4 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$781K |
| 5 |
Pfizer
PFE
|
+$701K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.46% |
| 2 | Financials | 19.6% |
| 3 | Materials | 10% |
| 4 | Technology | 8.95% |
| 5 | Industrials | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
DigitalBridge
DBRG
$2.99B
| $7K | ﹤0.01% |
367
| – | – |
|
102
Viatris
VTRS
$18.8B
| $5K | ﹤0.01% |
+80
| New | +$1.3K |
|
103
Alerian MLP ETF
AMLP
$13.4B
| $3K | ﹤0.01% |
120
| – | – |
|
|
SCU
104
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $3K | ﹤0.01% |
200
| – | – |
|
|
MBAI
105
Check-Cap
MBAI
$9.05M
| $1K | ﹤0.01% |
16
| – | – |
|
106
The RMR Group
RMR
$332M
| $1K | ﹤0.01% |
16
| – | – |
|
107
Wabtec
WAB
$49.4B
| $1K | ﹤0.01% |
23
| – | – |
|
108
Alkermes
ALKS
$7.95B
| – | – |
-38,000
| Closed | -$630K |
|
109
Collegium Pharmaceutical
COLL
$786M
| – | – |
-29,862
| Closed | -$622K |
|
110
Cardiff Oncology
CRDF
$73.1M
| – | – |
-5,000
| Closed | -$71K |
|
111
Cytokinetics
CYTK
$10B
| – | – |
-15,837
| Closed | -$343K |
|
112
Krystal Biotech
KRYS
$10.4B
| – | – |
-7,079
| Closed | -$305K |
|
|
SRCL
113
DELISTED
Stericycle Inc
SRCL
| – | – |
-160,000
| Closed | -$10.1M |
|
|
CCXI
114
DELISTED
ChemoCentryx, Inc.
CCXI
| – | – |
-6,587
| Closed | -$361K |
|
|
SBBP
115
DELISTED
Strongbridge Biopharma plc.
SBBP
| – | – |
-372,000
| Closed | -$781K |
|
Similar funds
FA
KCP
HCIA
ISG
TPCM
DCM
MCL
DVC
David M. Knott's Q4 2020 Portfolio in Review
As of Q4 2020, David M. Knott held 119 positions worth $221M, up 30% from $170M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
David M. Knott deployed $20.5M of net new capital in Q4 2020, opening 19 new positions and adding to 16 existing holdings. Its largest new stake was Midwest Holding Inc. Common Stock: 143,621 shares worth $7.71M.
By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 42% a quarter earlier, followed by Financials and Materials.
On the sell side, the largest reduction was LKQ Corp, an estimated $1.03M trimmed.
- David M. Knott's largest Q4 2020 buy was Midwest Holding Inc. Common Stock: 143,621 shares worth $7.71M.
- David M. Knott added most to Gilead Sciences in Q4 2020, an estimated $3.25M increase.
- David M. Knott's biggest Q4 2020 reduction was LKQ Corp, cutting an estimated $1.03M.
- David M. Knott fully exited Stericycle Inc in Q4 2020, selling an estimated $10.1M.
- David M. Knott's ten largest holdings make up 56% of its $221M portfolio in Q4 2020.
- David M. Knott opened 19 new positions and closed 9 in Q4 2020.
- David M. Knott's portfolio value rose 30% quarter-over-quarter to $221M.
Based on David M. Knott's 13F filing for Q4 2020, filed 12 Feb 2021.